Benefit? [SaneVax: The FDA/CDC and government health officials around the globe are brushing off adverse events experienced after HPV vaccinations as ‘coincidence’ despite the fact that these ‘coincidences’ are occurring at more than twice the rate of other vaccines. In direct response to government’s lack of concern independent research scientist, Dr. Chandler Marrs has taken up […]
HPV vaccination not cost effective
HPV vaccination programs have been shown to be not cost effective in countries with comprehensive Pap screening and surgery Abstract By Judy Wilyman Pap screening combined with loop electrosurgical excision procedures (LEEP) is almost 100% effective in preventing cervical cancer mortality yet many countries with these procedures have now implemented broad HPV vaccination programs. HPV […]
Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study
Prevalence Mohammadreza Haghshenas1, Tahereh Golini-moghaddam2, Alireza Rafiei1, Omid Emadeian2, Ahmad Shykhpour1 and G Hossein Ashrafi3* Abstract Background Cervical cancer is the greater cause of cancer death in women in many developing countries. Persistent infection with human papilloma virus (HPV), primarily high risk types 16 and 18, is recognized as a causal and essential factor for the development of cervical cancer. We […]
HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia
Genetic Predisposition Corresponding author: Ghazi Alsbeih galsbeih@kfshrc.edu.sa Background Cervical cancer incidence is low in Saudi Arabian women, suggesting low prevalence to HPV infection due to environmental, cultural and genetic differences. Therefore, we investigated HPV prevalence and genotype distribution in cervical cancer as well as the association with 9 genetic single nucleotide polymorphisms (SNPs): CDKN1A (p21) C31A, TP53 C72G, ATM G1853A, HDM2promoter T309G, HDM2 A110G, LIG4 A591G, XRCC1 G399A, XRCC3 C241T and TGFβ1 T10C, […]
Influenza: marketing vaccine by marketing disease
Influenza Influenza… by Peter Doshi, Postdoctoral Fellow: BMJ 2013;346:f3037 The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so. Promotion of flu vaccines is one of the most visible and aggressive public […]
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 60
- Next Page »
